Antiproliferative and metabolic effects of metformin in a preoperative window clinical trial for endometrial cancer

We conducted a preoperative window study of metformin in endometrial cancer (EC) patients and evaluated its antiproliferative, molecular and metabolic effects. Twenty obese women with endometrioid EC were treated with metformin (850 mg) daily for up to 4 weeks prior to surgical staging. Expression o...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cancer Med
Autores principales: Schuler, Kevin M, Rambally, Brooke S, DiFurio, Megan J, Sampey, Brante P, Gehrig, Paola A, Makowski, Liza, Bae-Jump, Victoria L
Formato: Artigo
Lenguaje:Inglês
Publicado: BlackWell Publishing Ltd 2015
Materias:
Cancer Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4329001/
https://ncbi.nlm.nih.gov/pubmed/25417601
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.353
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares